On July 16th, the FDA approved Orphengesic Forte, a non-opioid combination analgesic for the treatment of mild to moderate pain associated with acute musculoskeletal conditions. The FDA’s approval came earlier than expected, which many have viewed as a reinforcement of the FDA’s commitment to do everything in its power to combat the opioid epidemic. Orphengesic […] Continue
Medical cannabis continues to create a host of questions as related to workers’ compensation claims, including the legality of use, particularly as guidance and policies continue to be issued. On July 21st, the FDA issued draft guidance for clinical research with cannabis and cannabis-derived compounds. The guidance does not apply to fully synthetic versions of cannabis, which […] Continue
The Centers for Medicare & Medicaid Services (CMS) will be hosting a Section 111 Non-Group Health Plan (NGHP) webinar on August 13, 2020 at 1:00 PM EST, and can be accessed here. As with most CMS webinars and presentations, the format will be opening remarks by CMS followed by a presentation that will include NGHP […] Continue
Last month, we blogged about new functionality to the Medicare Secondary Payer Recovery Portal (MSPRP) to allow authorized users to view and print correspondence via the portal, which is now accessible. This is beneficial when correspondence related to the conditional payment recovery process has not been received. In addition, today, a new MSPRP User Guide […] Continue
A recent decision out of the United States District Court for the District of New Jersey is sending warning signals and a reminder to implement proactive practices to primary payers. The decision arises from Osterbye v. United States, 2020 U.S. Dist. LEXIS 116591, and came before the court on the Defendant’s Motion to Dismiss Plaintiff’s […] Continue